The phrase “dead as a Dodo” may no longer be applicable anymore as one Dallas-based company seeks to make extinction a thing of the past.
Colossal Biosciences has bioengineered a wolf that last roamed a vast range as far north as Canada and as far south as Venezuela some 10,000 years ago: the dire wolf. The company bred identical twin males named Romulus and Remus, and a younger female wolf named Khaleesi.
And just like that, these births may well have changed the concept of endangered species forever.
Colossal Biosciences co-founder and billionaire Ben Lamm, along with Chief Animal Officer Matt James and Chief Science Officer Beth Shapiro, spoke to Texas Standard about the accomplishmen – along with how they are treating the complicated ethical implications of such a feat.
Listen to the interview above or read the transcript below.
This transcript has been edited lightly for clarity:
Texas Standard: Well, so how did you do it?
Beth Shapiro: One of the first things that we wanted to do was figure out the dire wolf genome. We had a version of the dire wolf genome that didn’t have too many of the bases covered from 2021. So we had to go out and get a couple more bones and extract DNA and sequence the whole genome.
Then we had figure out what it is that makes a dire wolf different from its closest living relatives, and of course, what is its closest living relative? Turns out that’s a gray wolf. That’s great. Dire wolves look a little bit like gray wolves, but they’re bigger, more muscular.
And also we learned by studying its genome that it had a different coat, different texture, different color, different length… So we had to go and figure out what DNA sequences made those changes.